Report cover image

Global Carglumic Acid Market Growth, Size, Trends Analysis - By Dosage Form, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jun 25, 2025
Length 248 Pages
SKU # SPER20265971

Description

Carglumic Acid Market Introduction and Overview

According to SPER market research, ‘Global Carglumic Acid Market Size- By Dosage Form, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Carglumic Acid Market is predicted to reach 309.94 million by 2034 with a CAGR of 7.69%.

Carglumic acid is formed from N-acetyl glutamate and aids in ammonia elimination and detoxification by activating the first enzyme in the urea cycle. This medicine is particularly useful in the treatment of rare disorders such as propionic academia and methyl-malonic academia, which are autosomal recessive and frequently necessitate lifetime medical therapy to preserve normal health.

Restraints:The use of carglumic acid has been restricted by the high cost of acquiring raw materials, the increased capital required for processing the finished product, and certain negative consequences linked to carglumic acid treatments. Furthermore, rising research and development costs, combined with the high cost of medicine, have increased the cost of overall production, prompting customers to seek alternatives.

Scope of the report:
Report Metric Details Market size available for years 2021-2034 Base year considered 2024 Forecast period 2025-2034

Segments covered
By Dosage Form, By Distribution Channel

Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered
Apothecon Pharmaceuticals Pvt. Ltd, Recordati Rare Diseases Inc, Manus Aktteva Biopharma LLP, Dipharma Francis S.r.l, NURAY CHEMICALS, NOVITIUM PHARMA LLC, Suven Life Sciences Limited, Biophore India Pharmaceuticals Pvt Ltd, Rhyme Organics and Chemicals Ltd, Aktteva Biopharma LLP.

Global Carglumic Acid Market Segmentation:

By Dosage Form:Based on the Dosage Form, Global Carglumic Acid Market is segmented as; Orally Disintegrating Tablets, Dispersible Tablets.

By Distribution Channel:Based on the Distribution Channel, Global Carglumic Acid Market is segmented as; Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

248 Pages
1. Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPER’s internal database
2.1.4.Premium insight from KOL’s
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTER’s Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Carglumic Acid Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Carglumic Acid Market
7.Global Carglumic Acid Market, By Dosage Form (USD Million) 2021-2034
7.1.Orally Disintegrating Tablets
7.2.Dispersible Tablets
7.3.Others
8.Global Carglumic Acid Market, By Distribution Channel (USD Million) 2021-2034
8.1.Hospital Pharmacies
8.2.Retail Pharmacies
8.3.Online Pharmacies
9.Global Carglumic Acid Market, (USD Million) 2021-2034
9.1.Global Carglumic Acid Market Size and Market Share
10.Global Carglumic Acid Market, By Region, (USD Million) 2021-2034
10.1.Asia-Pacific
10.1.1.Australia
10.1.2.China
10.1.3.India
10.1.4.Japan
10.1.5.South Korea
10.1.6.Rest of Asia-Pacific
10.2.Europe
10.2.1.France
10.2.2.Germany
10.2.3.Italy
10.2.4.Spain
10.2.5.United Kingdom
10.2.6.Rest of Europe
10.3.Middle East and Africa
10.3.1.Kingdom of Saudi Arabia
10.3.2.United Arab Emirates
10.3.3.Qatar
10.3.4.South Africa
10.3.5.Egypt
10.3.6.Morocco
10.3.7.Nigeria
10.3.8.Rest of Middle-East and Africa
10.4.North America
10.4.1.Canada
10.4.2.Mexico
10.4.3.United States
10.5.Latin America
10.5.1.Argentina
10.5.2.Brazil
10.5.3.Rest of Latin America
11.Company Profile
11.1.Apothecon Pharmaceuticals Pvt. Ltd
11.1.1.Company details
11.1.2.Financial outlook
11.1.3.Product summary
11.1.4.Recent developments
11.2.Recordati Rare Diseases Inc
11.2.1.Company details
11.2.2.Financial outlook
11.2.3.Product summary
11.2.4.Recent developments
11.3.Manus Aktteva Biopharma LLP
11.3.1.Company details
11.3.2.Financial outlook
11.3.3.Product summary
11.3.4.Recent developments
11.4.Dipharma Francis S.r.l
11.4.1.Company details
11.4.2.Financial outlook
11.4.3.Product summary
11.4.4.Recent developments
11.5.NURAY CHEMICALS
11.5.1.Company details
11.5.2.Financial outlook
11.5.3.Product summary
11.5.4.Recent developments
11.6.NOVITIUM PHARMA LLC
11.6.1.Company details
11.6.2.Financial outlook
11.6.3.Product summary
11.6.4.Recent developments
11.7.Suven Life Sciences Limited
11.7.1.Company details
11.7.2.Financial outlook
11.7.3.Product summary
11.7.4.Recent developments
11.8.Biophore India Pharmaceuticals Pvt Ltd
11.8.1.Company details
11.8.2.Financial outlook
11.8.3.Product summary
11.8.4.Recent developments
11.9.Rhyme Organics and Chemicals Ltd
11.9.1.Company details
11.9.2.Financial outlook
11.9.3.Product summary
11.9.4.Recent developments
11.10.Aktteva Biopharma LLP
11.10.1.Company details
11.10.2.Financial outlook
11.10.3.Product summary
11.10.4.Recent developments
11.11.Others
12.Conclusion
13.List of Abbreviations
14.Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us